Facts
The French Athletics Federation (Fédération Française d'athlétisme, FFA) charges respondent M22 for a violation of the Anti-Doping Rules. During an athletic event on January 27, 2013, a sample was taken for doping test purposes. Analysis of the sample showed heptaminol and bumetanide which are prohibited substances according the World Anti-Doping Agency (WADA) prohibited list.
History
Respondent recognized throughout the procedure at having consumed a pharmaceutical product containing heptaminol and three days before the athletic event a pharmaceutical product containing bumetanide; she claims to have acted for therapeutic purposes, to treat pathologies in which she would suffer
occasionally or chronically: acute allergies, asthma, hemorrhoids crises and edema of the legs. She says have the medical proof for these pharmaceutical specialties.
However she was unable to provide documents covering the period of the Doping Control including certificates which gives rise to the prescription of drugs above, and specifying the conditions for the use of these products; she was also unable to produce the records of examinations attesting to the existence of her conditions; the products she mentions on the doping control form are not the substances detected in her urine. Under these circumstances the therapeutic purposes are not justifiable established.
Decision
1. The sanction is a period of ineligibility of one year in which respondent can't take part in competition or manifestations organized or authorized by the FFA and related federations.
2. All the results obtained at January 27, 2013, will be cancelled. Medals, points and prizes will be withdrawn.
3. The decision starts on the date of notification.
4. The decision will be published and sent to the parties involved.
